Rxcurve
Medicare Part B payment limits Effective October 1 – December 31, 2026 Posted by CMS September 17, 2026
HCPCS J9023 · per 10 MG

Injection, avelumab, 10 mg

Products billed under this code include Bavencio.

Payment limit per 10 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J9023

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Bavencio EMD Serono, Inc. 44087-3535-01 20 $2,179.88

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $108.994 +$0.358 10 MG Injection, avelumab, 10 mg v1, posted September 17, 2026
3Q26 $108.636 +$3.091 10 MG Injection, avelumab, 10 mg v1, posted September 15, 2026
2Q26 $105.545 +$0.559 10 MG Injection, avelumab, 10 mg v1, posted September 15, 2026
1Q26 $104.986 +$4.899 10 MG Injection, avelumab, 10 mg v1, posted September 15, 2026
4Q25 $100.087 −$0.212 10 MG Injection, avelumab, 10 mg v1, posted September 8, 2026
3Q25 $100.299 +$3.162 10 MG Injection, avelumab, 10 mg v1, posted March 10, 2026
2Q25 $97.137 +$0.189 10 MG Injection, avelumab, 10 mg v1, posted March 10, 2026
1Q25 $96.948 +$1.772 10 MG Injection, avelumab, 10 mg v1, posted December 19, 2025
4Q24 $95.176 +$0.449 10 MG Injection, avelumab, 10 mg v1, posted June 11, 2025
3Q24 $94.727 +$2.193 10 MG Injection, avelumab, 10 mg v1, posted June 11, 2025
2Q24 $92.534 +$0.165 10 MG Injection, avelumab, 10 mg v1, posted March 11, 2025
1Q24 $92.369 +$1.475 10 MG Injection, avelumab, 10 mg v1, posted December 19, 2024
4Q23 $90.894 +$0.325 10 MG Injection, avelumab, 10 mg v1, posted October 10, 2024
3Q23 $90.569 +$1.392 10 MG Injection, avelumab, 10 mg v1, posted June 5, 2024
2Q23 $89.177 −$0.158 10 MG Injection, avelumab, 10 mg v1, posted February 23, 2024
1Q23 $89.335 +$1.159 10 MG Injection, avelumab, 10 mg v1, posted December 6, 2023
4Q22 $88.176 −$0.20 10 MG Injection, avelumab, 10 mg v1, posted June 22, 2023
3Q22 $88.376 +$0.90 10 MG Injection, avelumab, 10 mg v1, posted June 9, 2023
2Q22 $87.476 −$0.132 10 MG Injection, avelumab, 10 mg v1, posted December 14, 2022
1Q22 $87.608 +$1.416 10 MG Injection, avelumab, 10 mg v1, posted June 8, 2022
4Q21 $86.192 +$0.195 10 MG Injection, avelumab, 10 mg v1, posted June 2, 2022
3Q21 $85.997 +$1.113 10 MG Injection, avelumab, 10 mg v1, posted June 2, 2022
2Q21 $84.884 −$0.447 10 MG Injection, avelumab, 10 mg v1, posted March 1, 2022
1Q21 $85.331 – 10 MG Injection, avelumab, 10 mg v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files